DigiKey launches MedTech Beyond video series

Digi-Key Electronics

Thursday, 14 December, 2023

Electronic components distributor DigiKey has announced the launch of its MedTech Beyond video series — a three-part series that dives into how medical devices are evolving and allowing for faster and more accurate diagnosis and treatment. From wearables to immersive tech and AI-powered innovations, the series explores how medical technology is creating opportunities to live longer, more fulfilling lives.

“As healthcare needs and technology both rapidly advance, DigiKey is proud to support the needed technology advancements,” said Josh Mickolio, Supplier Business Development Manager – Wireless and IoT for DigiKey. “Medtech advancements are enhancing every aspect of health care and ultimately leading to longer, more fulfilling lives.”

The first video in the series, ‘Holistic Health’, investigates the evolution of tech-assisted personal wellness and patient care. Personal wellness tech is no longer limited to counting steps: a new generation of patient care and personalised medical devices are using the latest technology to provide a better patient experience and a more holistic look at daily health.

The second video, ‘Engineering Better Health Outcomes’, explores how innovation happens behind the scenes with industry leaders. Given the critical importance of patient safety and security, medical device engineers, designers and supply chains face more pressure than most.

The third and final video in the first season of the series, ‘Curing Tomorrow’, examines the big thinkers investigating the next medtech breakthrough. From AI-powered diagnostics to predictive analytics, the video investigates how today’s innovations are helping diagnose and treat the diseases of tomorrow.

The video series is sponsored by NXP Semiconductors and RECOM Power — both of whom are key suppliers to the medtech industry — and is available now on the DigiKey website.

Related News

Repurposed drugs show promise in heart muscle regeneration

The FDA-approved medications, when given in combination, target two proteins that regulate the...

A pre-emptive approach to treating leukaemia relapse

The monitoring of measurable residual disease (MRD), medication and low-dose chemotherapy is...

Long COVID abnormalities appear to resolve over time

Researchers at UNSW's Kirby Institute have shown that biomarkers in long COVID patients have...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd